
Nov 16 (Reuters) – Clearmind Medicine Inc: * CLEARMIND ACHIEVES FULL ENROLLMENT FOR PART C IN CMND-100 PHASE I/IIA TRIAL, MARKING KEY CLINICAL MILESTONE Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Apollo Clinic and Apollo Diagnostic’ National Reference Laboratory, have joined forces together to establish a…
French football chief Diallo to challenge Infantino for FIFA presidency
VIDEO SHOWS: FILE OF FRENCH FOOTBALL FEDERATION PRESIDENT, PHILIPPE DIALLO COMPLETE SCRIPT TO FOLLOW SHOWS:…
Poland had budget deficit of 195.2 billion zlotys at end of October, PAP reports
WARSAW, Nov 16 (Reuters) - Poland had a budget deficit of 195.2 billion zlotys ($48.85…